FundedIQ
Health Care

ODI Pharma: Funding, Investors & Team (Sep 2026)

ODI Pharma AB, utilizing its extensive European network, subsidiaries, and affiliates, specializes in manufacturing pharmaceutical cannabis products primarily intended for the medicinal market in Europe. The company's primary focus lies in distributing medicinal cannabis products to clients and patients through its existing partnerships with pharmacies and wholesale distributors. The company was established and is currently led by a group of professionals who possess significant expertise as doctors, researchers, investors, and corporate managers. The main goal of ODI Pharma AB is to enhance the well-being of its patients and clients by offering innovative products, initiating and facilitating research, and advocating for alternative forms of medication.

www.odipharma.com Stockholm, Sweden 1-10 employees
Pharmaceutical B2B
Total raised
$380k
Rounds
1
Latest
Undisclosed round
Jun 2023

ODI Pharma has raised $380k across 1 funding round on record, the most recent an undisclosed round of $380k announced in Jun 2023.

That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.

ODI Pharma Company Profile and Key Stats

Total funding raised
$380k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$380k in Jun 2023
Employees
1-10
reported band
Headquarters
Stockholm, Sweden

Latest funding round on record: Jun 2023.

ODI Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
$380k

ODI Pharma Founders and Leadership Team

Name
Role
Contact
Derek Simmross
Founder

No contact details are on record for this team yet.

ODI Pharma Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.8M
691
$4.4M

ODI Pharma's latest round of $380k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ODI Pharma in Health Care and Stockholm

Companies Similar to ODI Pharma

Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…

Series C $700M

Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.

Undisclosed round $2.1M

Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…

Undisclosed round $2.6M

ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…

Undisclosed round $640k

Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…

Undisclosed round $520k

IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…

Undisclosed round $11.0M

The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…

Undisclosed round $3.3M

Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…

Undisclosed round $760k

B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…

Undisclosed round $4.5M

Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…

Undisclosed round $1.5M

Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…

Undisclosed round $3.0M

Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…

Angel $1.2M

ODI Pharma Funding FAQs

What does ODI Pharma do?

ODI Pharma AB, utilizing its extensive European network, subsidiaries, and affiliates, specializes in manufacturing pharmaceutical cannabis products primarily intended for the medicinal market in Europe. The company's primary focus lies in distributing medicinal cannabis products to clients and patients through its existing partnerships with pharmacies and wholesale distributors. The company was established and is currently led by a group of professionals who possess significant expertise as doctors, researchers, investors, and corporate managers. The main goal of ODI Pharma AB is to enhance the well-being of its patients and clients by offering innovative products, initiating and facilitating research, and advocating for alternative forms of medication.

How much funding has ODI Pharma raised?

ODI Pharma has raised $380k across 1 round on record. The most recent is an undisclosed round of $380k announced in Jun 2023.

When did ODI Pharma last raise funding?

ODI Pharma's most recent funding round on record is an undisclosed round of $380k, announced in Jun 2023.

Who founded ODI Pharma?

FundedIQ lists Derek Simmross (Founder) at ODI Pharma.

Where is ODI Pharma headquartered?

ODI Pharma is based in Stockholm, Stockholms Lan, Sweden.

How many employees does ODI Pharma have?

ODI Pharma is in the 1-10 employee band.

How does ODI Pharma's funding compare to other Health Care startups?

ODI Pharma's latest round of $380k is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's ODI Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ODI Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.